» Articles » PMID: 19091458

Liver Cancer: Descriptive Epidemiology and Risk Factors Other Than HBV and HCV Infection

Overview
Journal Cancer Lett
Specialty Oncology
Date 2008 Dec 19
PMID 19091458
Citations 147
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of liver cancer is high in all low-resource regions of the world, with the exception of Northern Africa and Western Asia. The estimated worldwide number of new cases of liver cancer in 2002 is 600,000, of which 82% are from developing countries. Given the poor survival from this disease, the estimated number of deaths is similar to that of new cases. Hepatocellular carcinoma (HCC) is the main form of liver cancer. A part from chronic infections with Hepatitis B and Hepatitis C viruses, which are the main causes of HCC, contamination of foodstuff with aflatoxins, a group of mycotoxins produced by the fungi Aspergillus flavus and Aspergillus parasiticus, is an important contributor to HCC burden in many low-income country. Alcoholic cirrhosis is an important risk factor for HCC in populations with low prevalence of HBV and HCV infection, and the association between tobacco smoking and HCC is now established. Diabetes is also related to an excess risk of HCC and the increased prevalence of overweight and obesity likely contributes to it. The second most important type of liver cancer is cholangiocarcinoma, whose main known cause is infestation with the liver flukes, Opistorchis viverrini and Clonorchis sinensis, which is frequent in some areas in South-East Asia. Angiosarcoma is a rare form of liver cancer whose occurence is linked to occupational exposure to vinyl chloride.

Citing Articles

Burden of five major types of gastrointestinal cancer in the Eastern Mediterranean Region.

Alessy S, Morgan E, Al-Zahrani A, Zahwe M, Fouad H, Bray F BMJ Open Gastroenterol. 2025; 12(1).

PMID: 39971587 PMC: 11840892. DOI: 10.1136/bmjgast-2024-001577.


Causal associations between dietary habits and liver cancer risk: a two-sample Mendelian randomization study.

Hu W, Sun J, Liu C Discov Oncol. 2025; 16(1):120.

PMID: 39909996 PMC: 11799489. DOI: 10.1007/s12672-025-01885-w.


State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.

Giron-Michel J, Padelli M, Oberlin E, Guenou H, Duclos-Vallee J BioDrugs. 2025; 39(2):237-260.

PMID: 39826071 PMC: 11906529. DOI: 10.1007/s40259-024-00702-0.


Global, regional, and national temporal trends in incidence and mortality for liver cancer due to hepatitis B, 1990-2021: a decomposition and age-period-cohort analysis for the Global Burden of Disease Study 2021.

Li J, Bai H, Gao Z, Gao L, Wang W, Li Y Hepatol Int. 2024; .

PMID: 39702656 DOI: 10.1007/s12072-024-10765-4.


Diagnostic performance of AI-based models versus physicians among patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Al-Obeidat F, Hafez W, Gador M, Ahmed N, Abdeljawad M, Yadav A Front Artif Intell. 2024; 7:1398205.

PMID: 39224209 PMC: 11368160. DOI: 10.3389/frai.2024.1398205.